5 Key Takeaways

• 1

  Accommodative intraocular lenses aim to restore natural vision lost to presbyopia in pseudophakic patients.

• 2

  Innovative accommodating IOLs are under development, with promising clinical outcomes but not yet definitive results.

• 3

  The only FDA-approved accommodating lenses in the U.S. are Crystalens and Trulign Toric, which are not widely used.

• 4

  FluidVision, Juvene, OmniVu, and JelliSee are among the new accommodating IOLs showing potential for improved vision.

• 5

  Clinical trials for these lenses report improvements in distance, intermediate, and near vision with favorable safety profiles.